Novartis AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novartis with three other
pharmaceutical manufacturers in Europe:
GlaxoSmithKline plc
of UNITED KINGDOM
(2019
sales of £33.75 billion [US$41.93 billion]
of which 52%
was Pharmaceuticals),
Sanofi S.A.
of FRANCE
(37.63 billion Euros [US$41.49 billion]
of which 68%
was Pharmaceuticals), and
Bayer AG
which is
based in GERMANY
(43.55 billion Euros [US$48.01 billion]
of which 46%
was CropScience).
Sales Analysis.
Novartis reported sales of 48.29 billion Swiss Francs (US$50.25 billion)
for the
year ending
December of 2019.
This
represents
a
decrease of 7.0%
versus 2018, when the company's sales were 51.94 billion Swiss Francs.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Novartis had sales
of 48.98 billion Swiss Francs.